The samples tested in this study are from the Solomon Islands, a population that is largely uncharacterized for CYP2D6. The Solomon Islands are striving towards P. vivax elimination and hence CYP2D6 characterization is valuable for informing 8-aminoquinoline malaria pharmacotherapeutic strategies in this population. Here, CYP2D6 is linked to malaria.